Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

108studies shown

Showing 76-100 of 108

WithdrawnNCT00470639

Transcranial Magnetic Stimulation for Depression in bipolarity

This study has public registry information. It focuses on depression and currently lists study information in Australia.

DepressionOtherFrom 18 Years to 80 Years

Countries: Australia
Sponsor: The University of New South Wales
Condition: Depression

View study

CompletedNCT03266679

Psychological Factors In The Treatment Of Bipolar Mood Disorders

This study is completed. It focuses on bipolarity and currently lists study information in Australia.

BipolarityOther

Countries: Australia
Sponsor: Queensland University of Technology
Condition: Bipolarity

View study

CompletedNCT00483548

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

This study is completed. It focuses on depression and currently lists study information in Australia, India, and the United States.

DepressionOtherOver 18 Years

Countries: Australia, India, United States
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition: Depression

View study

CompletedNCT03197974

RCT of a Web-based Intervention to Improve Quality of Life in Late Stage Bipolarity (ORBIT)

This study is completed. It focuses on bipolarity and currently lists study information in Australia.

BipolarityOtherFrom 18 Years to 65 Years

Countries: Australia
Sponsor: Swinburne University of Technology
Condition: Bipolarity

View study

CompletedNCT00436020

rTMS in the Treatment of Depression in bipolarity

This study is completed. It focuses on depression and currently lists study information in Australia.

DepressionOtherFrom 18 Years to 70 Years

Countries: Australia
Sponsor: Bayside Health
Condition: Depression

View study

TerminatedNCT01121536

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolarity I

This study has public registry information. It focuses on depression and currently lists study information in Argentina, Australia, Brazil, Bulgaria, Canada, Croatia, France, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Spain, Ukraine, and the United States.

DepressionOtherFrom 18 Years to 65 Years

Countries: Argentina, Australia, Brazil, Bulgaria, Canada, Croatia, France, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Spain, Ukraine, United States
Sponsor: Cephalon
Condition: Depression

View study

CompletedNCT00202293

Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features

This study is completed. It focuses on schizophrenia and currently lists study information in Australia.

SchizophreniaOtherFrom 15 Years to 29 Years

Countries: Australia
Sponsor: Melbourne Health
Condition: Schizophrenia

View study

CompletedNCT01890356

Maintenance Transcranial Electrical Stimulation for Depression

This study is completed. It focuses on depression and currently lists study information in Australia.

DepressionOtherOver 18 Years

Countries: Australia
Sponsor: The University of New South Wales
Condition: Depression

View study

CompletedNCT02118623

Internet-Based Interventions for Bipolarity (MoodSwings 2)

This study is completed. It focuses on bipolarity and currently lists study information in Australia.

BipolarityOtherFrom 21 Years to 65 Years

Countries: Australia
Sponsor: University of Melbourne
Condition: Bipolarity

View study

CompletedNCT00360126

An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolarity

This study is completed. It focuses on bipolarity and currently lists study information in Australia.

BipolarityOtherOver 18 Years

Countries: Australia
Sponsor: GlaxoSmithKline
Condition: Bipolarity

View study

CompletedNCT01358357

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

This study is completed. It focuses on bipolarity and currently lists study information in Argentina, Australia, Bulgaria, Chile, Croatia, Czech Republic, France, Hungary, Japan, Poland, Russian Federation, Serbia, Slovakia, and the United States.

BipolarityOtherOver 18 Years

Countries: Argentina, Australia, Bulgaria, Chile, Croatia, Czech Republic, France, Hungary, Japan, Poland, Russian Federation, Serbia, Slovakia, United States
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity

View study

CompletedNCT01072630

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolarity I

This study is completed. It focuses on depression and currently lists study information in Argentina, Australia, Bulgaria, Canada, France, Poland, South Africa, Spain, Ukraine, and the United States.

DepressionOtherFrom 18 Years to 65 Years

Countries: Argentina, Australia, Bulgaria, Canada, France, Poland, South Africa, Spain, Ukraine, United States
Sponsor: Cephalon
Condition: Depression

View study

CompletedNCT01562184

Investigating tDCS as a Treatment for Unipolar and Depression in bipolarity

This study is completed. It focuses on depression and currently lists study information in Australia and the United States.

DepressionOtherOver 18 Years

Countries: Australia, United States
Sponsor: The University of New South Wales
Condition: Depression

View study

CompletedNCT01339598

Remediation of Cognitive Dysfunction in Euthymic Bipolarity Patients Using Transcranial Direct Current Stimulation (tDCS)

This study is completed. It focuses on bipolarity and currently lists study information in Australia.

BipolarityOtherFrom 18 Years to 65 Years

Countries: Australia
Sponsor: The University of New South Wales
Condition: Bipolarity

View study

CompletedNCT01076361

Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study

This study is completed. It focuses on bipolarity and currently lists study information in Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, the Netherlands, Serbia and Montenegro, Spain, Sweden, Switzerland, and the United States.

BipolarityOther

Countries: Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Serbia and Montenegro, Spain, Sweden, Switzerland, United States
Sponsor: Medtronic
Condition: Bipolarity

View study

CompletedNCT05402657

The RAFT ECT Study

This study is completed. It focuses on depression and currently lists study information in Australia and the United States.

DepressionOtherOver 18 Years

Countries: Australia, United States
Sponsor: The George Institute
Condition: Depression

View study

CompletedNCT06003309

Frequency and E-field Enhancement of ITBS for Depression (FREED)

This study is completed. It focuses on depression and currently lists study information in Australia and the United States.

DepressionOtherFrom 18 Years to 80 Years

Countries: Australia, United States
Sponsor: University of California, San Diego
Condition: Depression

View study

RecruitingNCT07315516

Sleep and Stress Study

This study is recruiting. It focuses on anxiety and currently lists participation information in Australia.

AnxietyOtherOver 18 Years

Countries: Australia
Sponsor: RDC Clinical Pty Ltd
Condition: Anxiety

View study

Active Not RecruitingNCT05528302

Technology Assisted Cognitive Behavioural Therapy Intervention for Anxiety in People Living With Cognitive Impairment

This study is active but not recruiting. It focuses on anxiety and currently lists study information in Australia.

AnxietyOtherOver 18 Years

Countries: Australia
Sponsor: The University of Queensland
Condition: Anxiety

View study

CompletedNCT06593847

Multisite Virtual Reality Intervention for Speech Anxiety

This study is completed. It focuses on anxiety and currently lists study information in Australia, China, Germany, the Netherlands, and the United States.

AnxietyOtherFrom 18 Years to 70 Years

Countries: Australia, China, Germany, Netherlands, United States
Sponsor: Boston University Charles River Campus
Condition: Anxiety

View study

RecruitingNCT06483789

Efficacy and Safety of HB-1 for Panic Disorder

This study is recruiting. It focuses on anxiety and currently lists participation information in Australia.

AnxietyOtherFrom 18 Years to 65 Years

Countries: Australia
Sponsor: HB BioTech, LLC
Condition: Anxiety

View study

RecruitingNCT06947941

A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Australia, Canada, Japan, the United Kingdom, and the United States.

SchizophreniaOtherFrom 55 Years to 90 Years

Countries: Australia, Canada, Japan, United Kingdom, United States
Sponsor: Bristol-Myers Squibb
Condition: Schizophrenia

View study

TerminatedNCT05211947

A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study

This study has public registry information. It focuses on schizophrenia and currently lists study information in Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Japan, Lithuania, Malaysia, Mexico, the Netherlands, New Zealand, Norway, the Philippines, Poland, Portugal, Romania, Serbia, Slovakia, South Korea, Spain, Sweden, Taiwan, Turkey, Ukraine, the United Kingdom, and the United States.

SchizophreniaOtherFrom 18 Years to 51 Years

Countries: Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Japan, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Philippines, Poland, Portugal, Romania, Serbia, Slovakia, South Korea, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States
Sponsor: Boehringer Ingelheim
Condition: Schizophrenia

View study

CompletedNCT04846868

Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)

This study is completed. It focuses on schizophrenia and currently lists study information in Australia, Brazil, Canada, China, Colombia, Germany, Greece, Italy, Japan, Mexico, New Zealand, Norway, the Philippines, Poland, Sweden, Turkey, and the United States.

SchizophreniaOtherFrom 18 Years to 50 Years

Countries: Australia, Brazil, Canada, China, Colombia, Germany, Greece, Italy, Japan, Mexico, New Zealand, Norway, Philippines, Poland, Sweden, Turkey, United States
Sponsor: Boehringer Ingelheim
Condition: Schizophrenia

View study

CompletedNCT02751632

The Staged Treatment in Early Psychosis Study

This study is completed. It focuses on schizophrenia and currently lists study information in Australia.

SchizophreniaOtherFrom 12 Years to 25 Years

Countries: Australia
Sponsor: Orygen
Condition: Schizophrenia

View study